Holmlin R. Erik's Form 4 filing
Bionano Genomics, Inc. (BNGO) · filed Dec 1, 2021
- Accession no.
- 0001209191-21-067229
- Filed
- Dec 1, 2021
- Trade date
- Nov 29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $20.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Holmlin R. ErikCIK 0001579988 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | Common Stock | PPurchaseAcquired | +2,200 | $3.99 | +$8,778 | 2,200 | Indirect | |
| Nov 29, 2021 | Common Stock | PPurchaseAcquired | +2,675 | $3.99 | +$10,673.25 | 4,875 | Indirect | |
| Nov 29, 2021 | Common Stock | PPurchaseAcquired | +150 | $3.98 | +$597 | 5,025 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.